Editorial: New advancement in tumor microenvironment remodeling and cancer therapy

Yi Yao; Ying Shen; James C Yao; Xiangsheng Zuo

doi:10.3389/fcell.2024.1384567

Editorial: New advancement in tumor microenvironment remodeling and cancer therapy

Front Cell Dev Biol. 2024 Mar 7:12:1384567. doi: 10.3389/fcell.2024.1384567. eCollection 2024.

Authors

Yi Yao^{1

2}, Ying Shen^{3

4

5}, James C Yao⁶, Xiangsheng Zuo⁶

Affiliations

¹ Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
² Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, China.
³ State Key Laboratory of Oncology in South China, Guangzhou, China.
⁴ Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.
⁵ Sun Yat-sen University Cancer Center, Guangzhou, China.
⁶ Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.

No abstract available

Keywords: PD-L1; TME; cancer therapeutics; immune check inhibitor; tumor mutational burden.

Publication types

Editorial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. YY was supported by Natural Science Foundation of Hubei Province of China (2022CFB114). YS was supported by the Natural Science Foundation of China (NSFC) grant (82273314).